Takeda Pharmaceutical Co Ltd (TACHEM)

No results found for "".

Takeda Pharmaceutical Co Ltd (TACHEM)

C/P	Industry	Status	Ticker(s)	Issuer(s)	Size(m)		Tranches	Region	Date
IGC	HLTH	PRCD	TACHEM	Takeda Pharmaceutical Co Ltd	€3,600		4	APAC	Jun 29, 2020

Tranche #1Takeda Pharmaceutical Co Ltd

currency

EUR

size (m)

750.000

maturity

Jul 9, 2027

type

Fixed

tenor

7.000

call

registration

SEC Registered

benchmark

Swaps

ranking

Sr. Unsecured

moody's

Baa2

s&p

BBB+

fitch

size description

re-open/tap

ipt

MS+130 a

ipt-pxd

guidance

MS+110 a

spread

105

coupon

0.75%

spread set

price

99.63000

yield

0.753%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

Tranche #2Takeda Pharmaceutical Co Ltd

currency

EUR

size (m)

850.000

maturity

Jul 9, 2029

type

Fixed

tenor

9.000

call

registration

SEC Registered

benchmark

Swaps

ranking

Sr. Unsecured

moody's

Baa2

s&p

BBB+

fitch

size description

re-open/tap

ipt

MS+150 a

ipt-pxd

guidance

MS+130 a

spread

125

coupon

spread set

price

99.40300

yield

1.023%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

Tranche #3Takeda Pharmaceutical Co Ltd

currency

EUR

size (m)

1,000.000

maturity

Jul 9, 2032

type

Fixed

tenor

12.000

call

registration

SEC Registered

benchmark

Swaps

ranking

Sr. Unsecured

moody's

Baa2

s&p

BBB+

fitch

size description

re-open/tap

ipt

MS+180 a

ipt-pxd

guidance

MS+155 a

spread

150

coupon

1.375%

spread set

price

99.46500

yield

1.385%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

Tranche #4Takeda Pharmaceutical Co Ltd

currency

EUR

size (m)

1,000.000

maturity

Jul 9, 2040

type

Fixed

tenor

20.000

call

registration

SEC Registered

benchmark

Swaps

ranking

Sr. Unsecured

moody's

Baa2

s&p

BBB+

fitch

size description

re-open/tap

ipt

MS+225 a

ipt-pxd

guidance

MS+205 a

spread

200

coupon

spread set

price

98.65000

yield

2.043%

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

book size (m)

peak book (m)

x-covered

book attrition

nic

billing & delivering

active leads

joint leads

passive leads

co-managers

coordinating managers

Tranche Comments

7 yr: Registration: SEC Registered; Comments: EUR750m 7yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+130 area, guidance +110 area for exp 750m-1bn, tbp +105 for 750m. Books >1.35bn (peak 1.6bn), HR 96% vs DBR 02/27s +14.8 @ 106.22. MWC B+25, 2mPC>.; 9 yr: Registration: SEC Registered; Comments: EUR850m 9yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+150 area, guidance +130 area for exp 750m-1bn, tbp +125 for 850m. Books >1.25bn (peak 1.75bn). HR 93% vs DBR 02/29s+159.3 @107.27. MWC B+25, 3mPC>.; 12 yr: Registration: SEC Registered; Comments: EUR1bn 12yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+180 area, guidance +155 area for exp 750m-1bn, tbp +150 for 1bn. Books >1.75bn (peak 2.35bn). HR 108% vs DBR 02/30s+188.9 @ 104.98. MWC B+30, 3mPC.; 20 yr: Registration: SEC Registered; Comments: EUR1bn 20yr SEC-regd bmk. Part of 4-tr EUR. With USDs. Baa2/BBB+. BofA/MS(B&D). IPTs MS+225 area, guidance +205 area for exp 750m-1bn, tbp +200 for 1bn. Books >1.9bn (peak 2.25bn). HR 52% vs DBR 07/40s+225.8 @ 201.61. MWC B+35, 6mPC.;

Use of Proceeds

Repay outstanding borrowings and general corporate purposes

Hide Details

Explore all other Commentary & Deal Flow

Asset Backed Securities

sector/subsector profiles

High Yield

industry/subindustry profiles

Investment Grade

industry/subindustry profiles

Takeda Pharmaceutical Co Ltd (TACHEM)

Deal Details

Commentary

Deal Flow